세계의 유도만능줄기세포(iPS 세포) 시장 : 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2025-2032년)

Persistence Market Research has recently released a comprehensive report on the global iPS Cell Market, providing an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.

Key Insights:

• Induced Pluripotent Stem Cell Market Size (2025E): USD 3.2 Billion
• Projected Market Value (2032F): USD 5.3 Billion
• Global Market Growth Rate (CAGR 2025 to 2032): 7.50%

Induced Pluripotent Stem Cell Market- Report Scope:

The global iPS cell market is focused on induced pluripotent stem cells (iPSCs), which are gaining widespread importance for their ability to generate specialized cell types used for drug testing, disease modeling, regenerative medicine, and toxicity testing. This market is influenced by ongoing advancements in stem cell research and increasing investments in life sciences. The market's future growth is fueled by both academic and commercial entities' focus on understanding the roles of iPSCs in disease development, drug discovery, and personalized medicine.

Market Drivers:

The global iPS cell market is witnessing significant growth due to various factors. A key driver is the increasing investment in life science research, particularly the growing emphasis on regenerative medicine and disease modeling. With more companies focusing on stem cell-based therapies, the demand for iPSCs is expected to rise. In addition, advancements in iPSC technology have made drug screening more efficient, reducing the reliance on animal models and improving preclinical testing. Moreover, the ongoing research in North America and Europe, as well as the rising use of iPSCs for patient-specific drug screening, supports the expansion of the market. The demand for personalized medicine is also expected to provide further momentum to market growth, as iPSCs allow for patient-specific disease modeling and drug testing.

Market Restraints:

Despite the promising growth trajectory, the iPS cell market faces some hurdles. One of the primary challenges is the complexity and cost associated with iPSC production and maintenance, which may limit accessibility for smaller research institutions or emerging biotech firms. Additionally, ethical concerns surrounding stem cell research, along with stringent regulatory frameworks, can impede market expansion. There is also a need for improved standardization and protocols in iPSC generation, differentiation, and application to ensure consistency and reproducibility in research. These challenges are expected to be addressed through ongoing research, technological improvements, and evolving regulatory support.

Market Opportunities:

The iPS cell market offers substantial opportunities, particularly with the continued growth of the biotechnology and pharmaceutical industries. With an increased understanding of disease mechanisms, iPSCs offer unique opportunities for personalized drug development and disease treatment. Further investment in basic research, especially in academia and research institutes, is expected to provide fresh insights into how iPSCs can be used to better understand disease processes, leading to new therapeutic strategies. Additionally, the growing use of iPSCs in toxicity testing and clinical trials presents significant growth opportunities. The increasing collaboration between biotech firms and research institutes further enhances market potential, accelerating the commercialization of iPSC-based applications.

Key Questions Answered in the Report:

• What are the primary factors driving the global growth of the iPS cell market?
• How are advancements in stem cell technology influencing iPS cell-based applications?
• Which regions are seeing the highest demand for iPS cells in drug testing, regenerative medicine, and toxicity screening?
• What are the challenges and limitations associated with iPSC technology, and how can these be overcome?
• Who are the key players in the iPS cell market, and what strategies are they employing to expand their market presence?
• What are the emerging trends and future projections for the global iPS cell market?

Competitive Intelligence and Business Strategy:

Leading companies in the global iPS cell market are focusing on enhancing their research capabilities and expanding product portfolios. Key players such as FUJIFILM Cellular Dynamics, Stemcell Technologies, and ReproCELL are investing heavily in advancing iPSC technologies and developing solutions tailored to drug discovery and regenerative medicine. Strategic partnerships and collaborations with academic institutions and research organizations play a critical role in accelerating product development and market reach. These companies are also exploring innovative applications of iPSCs in disease modeling and personalized treatments, positioning themselves as leaders in the expanding life sciences field.

Key Companies Profiled:

• Thermo Fisher Scientific Inc.
• FUJIFILM Holdings Corporation (Cellular Dynamics)
• Horizon Discovery Group plc.
• Takara Bio Inc.
• Cell Applications, Inc.
• Lonza Group Ltd.
• Others.

Induced Pluripotent Stem Cell Market Segmentation:

By Cell Type:

• Hepatocytes
• Fibroblasts
• Keratinocytes
• Neurons
• Others

By Application:

• Drug Development
• Regenerative Medicine
• Toxicity Testing

By End User:

• Academic and Research Institutes
• Biotechnology Companies

By Region:

• North America
• Latin America
• Europe
• Asia Pacific excluding China (APEC)
• China
• Middle East and Africa (MEA)

Table of Contents

1. Executive Summary

• 1.1. Market Overview
• 1.2. Market Analysis
• 1.3. PMR Analysis and Recommendations
• 1.4. Wheel of Fortune

2. Market Introduction

• 2.1. Market Definition
• 2.2. Market Taxonomy

3. Induced Pluripotent Stem cells Market Opportunity Analysis

• 3.1. Macro-Economic Factors
• 3.2. Opportunity Analysis

4. Market Background

• 4.1. Parent Market Overview
• 4.2. Induced Pluripotent Stem Cell Timeline
• 4.3. Market Dynamics
  • 4.3.1. Drivers
  • 4.3.2. Restraints
  • 4.3.3. Trends

5. Macroeconomic Assumptions

6. Global Economic Outlook

• 6.1. Gross Domestic Product by Region & Country, 2025 - 2032
• 6.2. Healthcare Indicators

7. Key Inclusions

• 7.1. Usage Trend in Industry
• 7.2. Active Researchers in Stem Cell Research
• 7.3. Induced Pluripotent Stem Cell Therapy for Cardiovascular Disease
• 7.4. In-Vivo Modelling for Neurological Disorder Using Induced Pluripotent Stem Cells
• 7.5. Pipeline Assessment

8. North America Induced Pluripotent Stem Cells Market Analysis 2020 - 2024 and Forecast 2025 - 2032

• 8.1. Introduction
• 8.2. Regional Market Trends
• 8.3. Historical Market Size (US$ Bn) Trend Analysis By Country, 2020 - 2024
  • 8.3.1. U.S.
  • 8.3.2. Canada
• 8.4. Market Size (US$ Bn) Forecast By Country, 2025 - 2032
• 8.5. Historical Market Size (US$ Bn) Trend Analysis By Cell Type, 2020 - 2024
  • 8.5.1. Hepatocytes
  • 8.5.2. Fibroblasts
  • 8.5.3. Keratinocytes
  • 8.5.4. Neurons
  • 8.5.5. Others
• 8.6. Market Size (US$ Bn) Forecast By Cell Type, 2025 - 2032
• 8.7. Historical Market Size (US$ Bn) Trend Analysis By Application, 2020 - 2024
  • 8.7.1. Drug Development
  • 8.7.2. Toxicity testing
  • 8.7.3. Regenerative Medicine
  • 8.7.4. Others
• 8.8. Market Size (US$ Bn) Forecast By Application, 2025 - 2032
• 8.9. Historical Market Size (US$ Bn) Trend Analysis By End User, 2020 - 2024
  • 8.9.1. Academic & Research Institutes
  • 8.9.2. Biotechnology companies
  • 8.9.3. Others
• 8.10. Market Size (US$ Bn) Forecast By End User, 2025 - 2032
• 8.11. Drivers and Restraints: Impact Analysis
• 8.12. Market Attractiveness Analysis
  • 8.12.1. By Country
  • 8.12.2. By Cell Type
  • 8.12.3. By Application
  • 8.12.4. By End User
• 8.13. Key Market Participants - Intensity Mapping
• 8.14. Drivers and Restraints - Impact Analysis

9. Latin America Induced Pluripotent Stem Cells Market Analysis 2020 - 2024 and Forecast 2025 - 2032

• 9.1. Introduction
• 9.2. Regional Market Trends
• 9.3. Historical Market Size (US$ Bn) Trend Analysis By Country, 2020 - 2024
  • 9.3.1. Argentina
  • 9.3.2. Brazil
  • 9.3.3. Mexico
  • 9.3.4. Rest of Latin America
• 9.4. Market Size (US$ Bn) Forecast By Country, 2025 - 2032
• 9.5. Historical Market Size (US$ Bn) Trend Analysis By Cell Type, 2020 - 2024
  • 9.5.1. Hepatocytes
  • 9.5.2. Fibroblasts
  • 9.5.3. Keratinocytes
  • 9.5.4. Neurons
  • 9.5.5. Others
• 9.6. Market Size (US$ Bn) Forecast By Cell Type, 2025 - 2032
• 9.7. Historical Market Size (US$ Bn) Trend Analysis By Application, 2020 - 2024
  • 9.7.1. Drug Development
  • 9.7.2. Toxicity testing
  • 9.7.3. Regenerative Medicine
  • 9.7.4. Others
• 9.8. Market Size (US$ Bn) Forecast By Application, 2025 - 2032
• 9.9. Historical Market Size (US$ Bn) Trend Analysis By End User, 2020 - 2024
  • 9.9.1. Academic & Research Institutes
  • 9.9.2. Biotechnology companies
  • 9.9.3. Others
• 9.10. Market Size (US$ Bn) Forecast By End User, 2025 - 2032
• 9.11. Drivers and Restraints: Impact Analysis
• 9.12. Market Attractiveness Analysis
  • 9.12.1. By Country
  • 9.12.2. By Cell Type
  • 9.12.3. By Application
  • 9.12.4. By End User
• 9.13. Key Market Participants - Intensity Mapping
• 9.14. Drivers and Restraints - Impact Analysis
• 9.15. Key Mergers & Acquisitions

10. Europe Induced Pluripotent Stem Cells Market Analysis 2020 - 2024 and Forecast 2025 - 2032

• 10.1. Introduction
• 10.2. Regional Market Trends
• 10.3. Historical Market Size (US$ Bn) Trend Analysis By Country, 2020 - 2024
  • 10.3.1. Germany
  • 10.3.2. U.K.
  • 10.3.3. France
  • 10.3.4. Italy
  • 10.3.5. Spain
  • 10.3.6. Russia
  • 10.3.7. Rest of Europe
• 10.4. Market Size (US$ Bn) Forecast By Country, 2025 - 2032
• 10.5. Historical Market Size (US$ Bn) Trend Analysis By Cell Type, 2020 - 2024
  • 10.5.1. Hepatocytes
  • 10.5.2. Fibroblasts
  • 10.5.3. Keratinocytes
  • 10.5.4. Neurons
  • 10.5.5. Others
• 10.6. Market Size (US$ Bn) Forecast By Cell Type, 2025 - 2032
• 10.7. Historical Market Size (US$ Bn) Trend Analysis By Application, 2020 - 2024
  • 10.7.1. Drug Development
  • 10.7.2. Toxicity testing
  • 10.7.3. Regenerative Medicine
  • 10.7.4. Others
• 10.8. Market Size (US$ Bn) Forecast By Application, 2025 - 2032
• 10.9. Historical Market Size (US$ Bn) Trend Analysis By End User, 2020 - 2024
  • 10.9.1. Academic & Research Institutes
  • 10.9.2. Biotechnology companies
  • 10.9.3. Others
• 10.10. Market Size (US$ Bn) Forecast By End User, 2025 - 2032
• 10.11. Drivers and Restraints: Impact Analysis
• 10.12.Market Attractiveness Analysis
  • 10.12.1. By Country
  • 10.12.2. By Cell Type
  • 10.12.3. By Application
  • 10.12.4. By End User
• 10.13. Key Market Participants - Intensity Mapping
• 10.14. Drivers and Restraints - Impact Analysis
• 10.15. Key Mergers & Acquisitions

11. Asia Pacific Induced Pluripotent Stem Cells Market Analysis 2020 - 2024 and Forecast 2025 - 2032

• 11.1. Introduction
• 11.2. Regional Market Trends
• 11.3. Historical Market Size (US$ Bn) Trend Analysis By Country, 2020 - 2024
  • 11.3.1. Japan
  • 11.3.2. India
  • 11.3.3. Australia and New Zealand
  • 11.3.4. Rest of Asia Pacific
• 11.4. Market Size (US$ Bn) Forecast By Country, 2025 - 2032
• 11.5. Historical Market Size (US$ Bn) Trend Analysis By Cell Type, 2020 - 2024
  • 11.5.1. Hepatocytes
  • 11.5.2. Fibroblasts
  • 11.5.3. Keratinocytes
  • 11.5.4. Neurons
  • 11.5.5. Others
• 11.6. Market Size (US$ Bn) Forecast By Cell Type, 2025 - 2032
• 11.7. Historical Market Size (US$ Bn) Trend Analysis By Application, 2020 - 2024
  • 11.7.1. Drug Development
  • 11.7.2. Toxicity testing
  • 11.7.3. Regenerative Medicine
  • 11.7.4. Others
• 11.8. Market Size (US$ Bn) Forecast By Application, 2025 - 2032
• 11.9. Historical Market Size (US$ Bn) Trend Analysis By End User, 2020 - 2024
  • 11.9.1. Academic & Research Institutes
  • 11.9.2. Biotechnology companies
  • 11.9.3. Others
• 11.10. Market Size (US$ Bn) Forecast By End User, 2025 - 2032
• 11.11. Drivers and Restraints: Impact Analysis
• 11.12. Market Attractiveness Analysis
  • 11.12.1. By Country
  • 11.12.2. By Cell Type
  • 11.12.3. By Application
  • 11.12.4. By End User
• 11.13. Key Market Participants - Intensity Mapping
• 11.14. Drivers and Restraints - Impact Analysis
• 11.15. Key Mergers & Acquisitions

12. China Induced Pluripotent Stem Cells Market Analysis 2020 - 2024 and Forecast 2025 - 2032

• 12.1. Introduction
• 12.2. Key Regulations
• 12.3. Historical Market Size (US$ Bn) Trend Analysis By Cell Type, 2020 - 2024
  • 12.3.1. Hepatocytes
  • 12.3.2. Fibroblasts
  • 12.3.3. Keratinocytes
  • 12.3.4. Neurons
  • 12.3.5. Others
• 12.4. Market Size (US$ Bn) Forecast By Cell Type, 2025 - 2032
• 12.5. Historical Market Size (US$ Bn) Trend Analysis By Application, 2020 - 2024
  • 12.5.1. Drug Development
  • 12.5.2. Toxicity testing
  • 12.5.3. Regenerative Medicine
  • 12.5.4. Others
• 12.6. Market Size (US$ Bn) Forecast By Application, 2025 - 2032
• 12.7. Historical Market Size (US$ Bn) Trend Analysis By End User, 2020 - 2024
  • 12.7.1. Academic & Research Institutes
  • 12.7.2. Biotechnology companies
  • 12.7.3. Others
• 12.8. Market Size (US$ Bn) Forecast By End User, 2025 - 2032
• 12.9. Drivers and Restraints: Impact Analysis
• 12.10. Market Attractiveness Analysis
  • 12.10.1. By Cell Type
  • 12.10.2. By Application
  • 12.10.3. By End User
• 12.11. Key Market Participants - Intensity Mapping
• 12.12. Drivers and Restraints - Impact Analysis
• 12.13. Key Mergers & Acquisitions

13. Middle East & Africa Induced Pluripotent Stem Cells Market Analysis 2020 - 2024 and Forecast 2025 - 2032

• 13.1. Introduction
• 13.2. Key Regulations
• 13.3. Historical Market Size (US$ Bn) Trend Analysis By Country, 2020 - 2024
  • 13.3.1. GCC Countries
  • 13.3.2. South Africa
  • 13.3.3. Rest of MEA
• 13.4. Market Size (US$ Bn) Forecast By Country, 2025 - 2032
• 13.5. Historical Market Size (US$ Bn) Trend Analysis By Cell Type, 2020 - 2024
  • 13.5.1. Hepatocytes
  • 13.5.2. Fibroblasts
  • 13.5.3. Keratinocytes
  • 13.5.4. Neurons
  • 13.5.5. Others
• 13.6. Market Size (US$ Bn) Forecast By Cell Type, 2025 - 2032
• 13.7. Historical Market Size (US$ Bn) Trend Analysis By Application, 2020 - 2024
  • 13.7.1. Drug Development
  • 13.7.2. Toxicity testing
  • 13.7.3. Regenerative Medicine
  • 13.7.4. Others
• 13.8. Market Size (US$ Bn) Forecast By Application, 2025 - 2032
• 13.9. Historical Market Size (US$ Bn) Trend Analysis By End User, 2020 - 2024
  • 13.9.1. Academic & Research Institutes
  • 13.9.2. Biotechnology companies
  • 13.9.3. Others
• 13.10. Market Size (US$ Bn) Forecast By End User, 2025 - 2032
• 13.11. Drivers and Restraints: Impact Analysis
• 13.12. Market Attractiveness Analysis
  • 13.12.1. By Country
  • 13.12.2. By Cell Type
  • 13.12.3. By Application
  • 13.12.4. By End User
• 13.13. Key Market Participants - Intensity Mapping
• 13.14. Drivers and Restraints - Impact Analysis
• 13.15. Key Mergers & Acquisitions

14. Forecast Factors: Relevance and Impact

15. Forecast Assumptions

16. Market Structure Analysis

• 16.1. Market Structure by Tier of Companies
• 16.2. Market Share Analysis (2024) for Top Players, By Region

17. Competition Analysis

• 17.1. Competition Dashboard
• 17.2. Competition Benchmarking
• 17.3. Company Deep Dive
  • 17.3.1. Thermo Fisher Scientific Inc.
    • 17.3.1.1. Overview
    • 17.3.1.2. Product and Application Portfolio
    • 17.3.1.3. Production Footprint
    • 17.3.1.4. Sales Footprint
    • 17.3.1.5. Channel Footprint
    • 17.3.1.6. Strategy
      • 17.3.1.6.1. Marketing Strategy
      • 17.3.1.6.2. Product Strategy
      • 17.3.1.6.3. Channel Strategy
  • 17.3.2. FUJIFILM Holdings Corporation (Cellular Dynamics)
    • 17.3.2.1. Overview
    • 17.3.2.2. Product and Application Portfolio
    • 17.3.2.3. Production Footprint
    • 17.3.2.4. Sales Footprint
    • 17.3.2.5. Channel Footprint
    • 17.3.2.6. Strategy
      • 17.3.2.6.1. Marketing Strategy
      • 17.3.2.6.2. Product Strategy
      • 17.3.2.6.3. Channel Strategy
  • 17.3.3. Horizon Discovery Group plc.
    • 17.3.3.1. Overview
    • 17.3.3.2. Product and Application Portfolio
    • 17.3.3.3. Production Footprint
    • 17.3.3.4. Sales Footprint
    • 17.3.3.5. Channel Footprint
    • 17.3.3.6. Strategy
      • 17.3.3.6.1. Marketing Strategy
      • 17.3.3.6.2. Product Strategy
      • 17.3.3.6.3. Channel Strategy
  • 17.3.4. Takara Bio Inc.
    • 17.3.4.1. Overview
    • 17.3.4.2. Product and Application Portfolio
    • 17.3.4.3. Production Footprint
    • 17.3.4.4. Sales Footprint
    • 17.3.4.5. Channel Footprint
    • 17.3.4.6. Strategy
      • 17.3.4.6.1. Marketing Strategy
      • 17.3.4.6.2. Product Strategy
      • 17.3.4.6.3. Channel Strategy
  • 17.3.5. Cell Applications, Inc.
    • 17.3.5.1. Overview
    • 17.3.5.2. Product and Application Portfolio
    • 17.3.5.3. Production Footprint
    • 17.3.5.4. Sales Footprint
    • 17.3.5.5. Channel Footprint
    • 17.3.5.6. Strategy
      • 17.3.5.6.1. Marketing Strategy
      • 17.3.5.6.2. Product Strategy
      • 17.3.5.6.3. Channel Strategy
  • 17.3.6. Lonza Group Ltd.
    • 17.3.6.1. Overview
    • 17.3.6.2. Product and Application Portfolio
    • 17.3.6.3. Production Footprint
    • 17.3.6.4. Sales Footprint
    • 17.3.6.5. Channel Footprint
    • 17.3.6.6. Strategy
      • 17.3.6.6.1. Marketing Strategy
      • 17.3.6.6.2. Product Strategy
      • 17.3.6.6.3. Channel Strategy

18. Global Induced Pluripotent Stem Cells Market Analysis 2020 - 2024 and Forecast 2025 - 2032, By Region

• 18.1. Introduction/Key Findings
• 18.2. Historical Market Size (US$ Bn) Trend Analysis By Region, 2020 - 2024
• 18.3. Market Size (US$ Bn) Forecast By Region, 2025 - 2032
  • 18.3.1. North America
  • 18.3.2. Latin America
  • 18.3.3. Europe
  • 18.3.4. Asia Pacific
  • 18.3.5. Middle East & Africa
  • 18.3.6. China
• 18.4. Market Attractiveness Analysis By Region

19. Global Induced Pluripotent Stem Cells Analysis 2020 - 2024 and Forecast 2025 - 2032, By Cell Type

• 19.1. Introduction/Key Findings
• 19.2. Historical Market Size (US$ Bn) Trend Analysis By Cell Type, 2020 - 2024
  • 19.2.1. Hepatocytes
  • 19.2.2. Fibroblasts
  • 19.2.3. Keratinocytes
  • 19.2.4. Neurons
  • 19.2.5. Others
• 19.3. Market Size (US$ Bn) Forecast By Cell Type, 2025 - 2032
• 19.4. Market Attractiveness Analysis By Cell Type

20. Global Induced Pluripotent Stem Cells Market Analysis 2020 - 2024 and Forecast 2025 - 2032, By Application

• 20.1. Introduction/Key Findings
• 20.2. Historical Market Size (US$ Bn) Trend Analysis By Application, 2020 - 2024
  • 20.2.1. Drug Development
  • 20.2.2. Toxicity testing
  • 20.2.3. Regenerative Medicine
  • 20.2.4. Others
• 20.3. Market Size (US$ Bn) Forecast By Application, 2025 - 2032
• 20.4. Market Attractiveness Analysis By Application

21. Global Induced Pluripotent Stem Cells Market Analysis 2020 - 2024 and Forecast 2025 - 2032, By End User

• 21.1. Introduction/Key Findings
• 21.2. Historical Market Size (US$ Bn) Trend Analysis By End User, 2020 - 2024
  • 21.2.1. Academic & Research Institutes
  • 21.2.2. Biotechnology companies
  • 21.2.3. Others
• 21.3. Market Size (US$ Bn) Forecast By End User, 2025 - 2032
• 21.4. Market Attractiveness Analysis By End User

22. Global Induced Pluripotent Stem Cells Market Analysis 2020 - 2024 and Forecast 2025 - 2032

• 22.1. Market Value Share Analysis By All Segment
• 22.2. Y-o-Y Growth Analysis By All Segment
• 22.3. Absolute $ Opportunity

23. Assumptions and Acronyms

24. Research Methodology